STEVEN SHING YAN CHEUNG M.D.
Prescription History 1669880613
Surgery - Vascular Surgery in Columbia, MO

Active since July 22, 2014PECOS EnrolledAccepts Medicare Assignment
100/100
CMS Quality Rating
1 HOSPITAL DR, COLUMBIA, MO 65212(573) 884-3278(573) 884-5046 Get Directions

NPPES record last updated: May 20, 2024. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Record update history: Oct 5, 2022, Sep 30, 2021 (2 updates tracked since 2021).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for STEVEN SHING YAN CHEUNG M.D., an active Vascular Surgery specialist practicing in Columbia, MO. Our medical registry currently tracks 2 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 34 documented patient claims. Among these therapy options, the most frequently utilized medication is Clopidogrel, which accounts for 19 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

2
Medications
34
Total Claims
52
30-Day Fills
Clopidogrel
Most Prescribed · 19 claims
View details
2 medications · 2024 Medicare Part D
Medicare Part D medications prescribed by STEVEN SHING YAN CHEUNG M.D. in 2024, with prescription volumes, average cost per fill, and MO state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other MO PrescribersVs. MO Avg
ClopidogrelClopidogrel Bisulfate19$3.61▼ below MO avg▼ Less than typical

About Clopidogrel: Clopidogrel is used to prevent heart attacks and strokes in persons with heart disease (recent heart attack), recent stroke, or blood circulation disease (peripheral vascular disease). Show more ▾

It is also used with aspirin to treat new/worsening chest pain (new heart attack, unstable angina) and to keep blood vessels open and prevent blood clots after certain procedures (such as cardiac stent). Clopidogrel works by blocking platelets from sticking together and prevents them from forming harmful clots. It is an antiplatelet drug. It helps keep blood flowing smoothly in your body. A ticlopidine analog and platelet purinergic P2Y receptor antagonist that inhibits adenosine diphosphate-mediated PLATELET AGGREGATION. It is used to prevent THROMBOEMBOLISM in patients with ARTERIAL OCCLUSIVE DISEASES; MYOCARDIAL INFARCTION; STROKE; or ATRIAL FIBRILLATION.

In 2024, this provider wrote 19 Medicare prescriptions for Clopidogrel, about a quarter of the volume of the typical Missouri prescriber of this medication (73.9). Medicare paid an average of $3.61 per fill, versus $9.48 statewide.

How often this provider prescribes it

This provider
19
MO average
73.9

This provider prescribes this medication less often than the average MO prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$3.61
MO average
$9.48

This provider's average cost per fill is below the MO average for this medication.

29
30-Day Fills
standardized to 30-day supplies
870
Days of Medication
total across all patients in 2024
EliquisApixaban15$904.05▼ Less than typical

About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾

With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. An antithrombotic agent.

In 2024, this provider wrote 15 Medicare prescriptions for Eliquis, about 14% of the volume of the typical Missouri prescriber of this medication (110.4). Medicare paid an average of $904.05 per fill, versus $777.14 statewide.

How often this provider prescribes it

This provider
15
MO average
110.4

This provider prescribes this medication less often than the average MO prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$904.05
MO average
$777.14

Gross Part D cost per fill; not the patient's out-of-pocket price.

23
30-Day Fills
standardized to 30-day supplies
690
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average MO prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the MO average cost per fill.

About this data. The prescription history for STEVEN SHING YAN CHEUNG M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Vascular Surgery prescribing approach at this Columbia, MO practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MO prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.